{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:07:11Z","timestamp":1779530831763,"version":"3.53.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"49","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,5]]},"abstract":"<jats:p>Despite widespread clinical use of the long-acting local anesthetic ropivacaine, its population-level safety remains under-explored. This study aimed to analyze and categorize adverse events (AE) associated with ropivacaine reported in the US Food and Drug Administration Adverse Event Reporting System (FAERS). We retrospectively extracted reports on adverse drug events (ADEs) from the FAERS database from the first quarter of 2004 to the fourth quarter of 2024. Using disproportionality analysis, including the reporting odds ratio, proportional reporting ratio, Bayesian confidence propagation neural network, and the empirical Bayesian geometric mean, we assessed whether there was a significant association between ropivacaine and ADEs. The Weibull shape parameter was used to test the time to onset curve. The Kaplan\u2013Meier method was employed to evaluate the cumulative incidence. In the FAERS database, ropivacaine was identified as the primary suspect in 1463 AE reports. The adverse reactions induced by ropivacaine involved 3 system organ categories and 21 high-level group terms. At the preferred term level, 181 positive ADEs were detected. Common ADEs included complications of anesthesia, Horner\u2019s syndrome, delayed awakening after anesthesia, systemic toxicity of local anesthetics, and monoparesis. Gender differences existed in ADEs related to ropivacaine. The median time to onset of ADEs related to ropivacaine was 2 days (range: 1\u20133 days). Weibull shape parameter testing revealed an early failure pattern for ropivacaine-associated ADEs. This pharmacovigilance study identifies significant safety signals associated with ropivacaine, particularly neurological and cardiac events that predominantly occur within the first 72 hours after administration. The detection of potential gender-specific reporting patterns and specific high-strength signals warrants further clinical investigation. These findings provide valuable hypothesis-generating evidence from real-world data to guide targeted monitoring and inform future research on ropivacaine\u2019s safety profile.<\/jats:p>","DOI":"10.1097\/md.0000000000046145","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T22:00:27Z","timestamp":1764972027000},"page":"e46145","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacovigilance assessment of ropivacaine safety using FAERS data (2004\u20132024)"],"prefix":"10.1097","volume":"104","author":[{"given":"Congcong","family":"Lai","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Xiangshan Hospital of TCM Medical and Health Group, Ningbo, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengguang","family":"Bao","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Xiangshan Hospital of TCM Medical and Health Group, Ningbo, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Xiangshan Hospital of TCM Medical and Health Group, Ningbo, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9328-8450","authenticated-orcid":false,"given":"Ruichun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Ningbo No. 2 Hospital, Ningbo, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260523","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.3390\/ijms252413487","article-title":"The study of ropivacaine pharmacokinetics in a clinical setting: a critical scoping review from the perspective of analytical methodologies.","volume":"25","author":"Butiulca","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R2-20260523","doi-asserted-by":"crossref","first-page":"1465308","DOI":"10.3389\/fmed.2024.1465308","article-title":"A bibliometrics and visualization analysis of ropivacaine research from 2000 to 2023.","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Med"},{"key":"R3-20260523","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003495-199652030-00012","article-title":"Ropivacaine.","volume":"52","author":"Markham","year":"1996","journal-title":"Drugs"},{"key":"R4-20260523","doi-asserted-by":"crossref","first-page":"1426512","DOI":"10.3389\/fmed.2024.1426512","article-title":"The optimal dose of dexmedetomidine as a 0.59% ropivacaine adjuvant for epidural anesthesia in great saphenous varicose vein surgery, based on hemodynamics and anesthesia efficacy: a randomized, controlled, double-blind clinical trial.","volume":"11","author":"Zeng","year":"2024","journal-title":"Front Med"},{"key":"R5-20260523","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/JS9.0000000000000821","article-title":"Pre-emptive infiltration with betamethasone and ropivacaine for postoperative pain in laminoplasty and laminectomy (PRE-EASE): a prospective randomized controlled trial.","volume":"110","author":"Shrestha","year":"2023","journal-title":"Int J Surg"},{"key":"R6-20260523","doi-asserted-by":"crossref","first-page":"110698","DOI":"10.1016\/j.jclinane.2022.110698","article-title":"Optimum programmed intermittent epidural bolus interval time between 8\u2009mL boluses of Ropivacaine 0.1% with sufentanil 0.3 \u03bcg\/mL with dural puncture epidural technique for labor analgesia: a biased-coin up-and-down sequential allocation trial.","volume":"79","author":"Song","year":"2022","journal-title":"J Clin Anesth"},{"key":"R7-20260523","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/rapm-2023-104667","article-title":"Local anesthetic dosing and toxicity of adult truncal catheters: a narrative review of published practice.","volume":"49","author":"Bungart","year":"2024","journal-title":"Reg Anesth Pain Med"},{"key":"R8-20260523","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/ALN.0000000000004389","article-title":"Local anesthetic cardiac toxicity is mediated by cardiomyocyte calcium dynamics.","volume":"137","author":"Plakhotnik","year":"2022","journal-title":"Anesthesiology"},{"key":"R9-20260523","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/rapm-2023-104964","article-title":"Inhibition of the glutamatergic PVT-NAc projections attenuates local anesthetic-induced neurotoxic behaviors.","volume":"50","author":"Zou","year":"2025","journal-title":"Reg Anesth Pain Med"},{"key":"R10-20260523","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00002018-200932040-00008","article-title":"Adverse drug reactions to local anaesthetics: a review of the French pharmacovigilance database.","volume":"32","author":"Fuzier","year":"2009","journal-title":"Drug Saf"},{"key":"R11-20260523","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1080\/14740338.2018.1474200","article-title":"A comparison of approaches to identify possible cases of local anesthetic systemic toxicity in the FDA Adverse Event Reporting System (FAERS) database.","volume":"17","author":"Dagenais","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"R12-20260523","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11060-020-03687-2","article-title":"Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database.","volume":"152","author":"Mikami","year":"2021","journal-title":"J Neurooncol"},{"key":"R13-20260523","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s40264-021-01082-y","article-title":"Reporting of thromboembolic events with JAK Inhibitors: analysis of the FAERS database 2010-2019.","volume":"44","author":"Setyawan","year":"2021","journal-title":"Drug Saf"},{"key":"R14-20260523","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1097\/JS9.0000000000002194","article-title":"Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database.","volume":"111","author":"Liu","year":"2025","journal-title":"Int J Surg"},{"key":"R15-20260523","doi-asserted-by":"crossref","first-page":"1365706","DOI":"10.3389\/fphar.2024.1365706","article-title":"Clinical adverse events to dexmedetomidine: a real-world drug safety study based on the FAERS database.","volume":"15","author":"Liu","year":"2024","journal-title":"Front Pharmacol"},{"key":"R16-20260523","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s12887-023-04126-7","article-title":"Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database.","volume":"23","author":"Schweitzer-Chaput","year":"2023","journal-title":"BMC Pediatr"},{"key":"R17-20260523","doi-asserted-by":"crossref","first-page":"20420986251332740","DOI":"10.1177\/20420986251332740","article-title":"Mydriasis mediated by local anesthetics: an unexpected adverse event or new therapeutic indication?","volume":"16","author":"Contreras-Salinas","year":"2025","journal-title":"Ther Adv Drug Saf"},{"key":"R18-20260523","doi-asserted-by":"crossref","first-page":"116385","DOI":"10.1016\/j.socscimed.2023.116385","article-title":"A gender hypothesis of sex disparities in adverse drug events.","volume":"339","author":"Lee","year":"2023","journal-title":"Soc Sci Med"},{"key":"R19-20260523","doi-asserted-by":"crossref","first-page":"842","DOI":"10.23736\/S0375-9393.22.16284-X","article-title":"Evaluation of the effect of dexmedetomidine combined with ropivacaine in epidural labor analgesia: a systematic review and meta-analysis.","volume":"88","author":"Zhou","year":"2022","journal-title":"Minerva Anestesiol"},{"key":"R20-20260523","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12871-024-02767-4","article-title":"The impact of epidural ropivacaine versus levobupivacaine for labor analgesia on maternal and fetal outcomes: a meta-analysis.","volume":"24","author":"Li","year":"2024","journal-title":"BMC Anesthesiol"},{"key":"R21-20260523","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ams2.265","article-title":"Local anesthetic toxicity: acute and chronic management.","volume":"4","author":"Sekimoto","year":"2017","journal-title":"Acute Med Surg"},{"key":"R22-20260523","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/00000542-200312000-00031","article-title":"Cardiac arrest after injection of ropivacaine for posterior lumbar plexus blockade.","volume":"99","author":"Huet","year":"2003","journal-title":"Anesthesiology"},{"key":"R23-20260523","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1213\/01.ANE.0000075839.18073.37","article-title":"Successful resuscitation after ropivacaine-induced ventricular fibrillation.","volume":"97","author":"Klein","year":"2003","journal-title":"Anesth Analg"},{"key":"R24-20260523","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1213\/ANE.0000000000002435","article-title":"Recovery from ropivacaine-induced or levobupivacaine-induced cardiac arrest in rats: comparison of lipid emulsion effects.","volume":"125","author":"Yoshimoto","year":"2017","journal-title":"Anesth Analg"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T10:01:38Z","timestamp":1779530498000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":24,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046145","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"2025-07-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}